{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:57:03Z","timestamp":1761101823476},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T00:00:00Z","timestamp":1162339200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Gastro"],"published-print":{"date-parts":[[2006,11]]},"DOI":"10.1007\/s11938-006-0005-8","type":"journal-article","created":{"date-parts":[[2007,6,3]],"date-time":"2007-06-03T17:14:49Z","timestamp":1180890889000},"page":"484-496","source":"Crossref","is-referenced-by-count":10,"title":["Liver involvement in cystic fibrosis"],"prefix":"10.1007","volume":"9","author":[{"given":"Catherine","family":"Brigman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Feranchak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"5_CR1","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1136\/adc.77.6.493","volume":"77","author":"JA Dodge","year":"1997","unstructured":"Dodge JA, Morison S, Lewis PA, et al.: Incidence, population, and survival of cystic fibrosis in the UK, 1968\u201395. UK Cystic Fibrosis Survey Management Committee. Arch Dis Child 1997, 77:493\u2013496.","journal-title":"Arch Dis Child"},{"key":"5_CR2","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/(SICI)1097-0258(19960315)15:5<449::AID-SIM173>3.0.CO;2-X","volume":"15","author":"MR Kosorok","year":"1996","unstructured":"Kosorok MR, Wei WH, Farrell PM: The incidence of cystic fibrosis. Stat Med 1996, 15:449\u2013462.","journal-title":"Stat Med"},{"key":"5_CR3","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1126\/science.2475911","volume":"245","author":"JR Riordan","year":"1989","unstructured":"Riordan JR, Rommens JM, Kerem B, et al.: Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 1989, 245:1066\u20131073.","journal-title":"Science"},{"key":"5_CR4","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/0140-6736(90)92672-5","volume":"335","author":"KJ Gaskin","year":"1990","unstructured":"Gaskin, KJ, Waters DL, de Silva M, et al.: Liver disease and bile duct stenosis in cystic fibrosis. Lancet 1990, 335:1098.","journal-title":"Lancet"},{"key":"5_CR5","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/hep.510300527","volume":"30","author":"A Linblad","year":"1999","unstructured":"Linblad A, Glaumann H, Strandvik B: Natural history of liver disease in cystic fibrosis. Hepatology 1999, 30:1151\u20131158.","journal-title":"Hepatology"},{"key":"5_CR6","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1053\/jhep.2002.37136","volume":"36","author":"C Colombo","year":"2002","unstructured":"Colombo C, Battezzati PM, Crosignani A, et al.: Liver disease in cystic fibrosis: a prospective study on incidence, risk factors, and outcome. Hepatology 2002, 36:1374\u20131382.","journal-title":"Hepatology"},{"key":"5_CR7","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/0016-5085(93)91085-V","volume":"105","author":"J Cohn","year":"1993","unstructured":"Cohn J, Strong T, Picciotto M, et al.: Localization of the cystic fibrosis transmembrane conductance regulator in human bile duct epithelial cells. Gastroenterology 1993, 105:1857\u20131864.","journal-title":"Gastroenterology"},{"key":"5_CR8","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1136\/thorax.56.10.746","volume":"56","author":"R Sharma","year":"2001","unstructured":"Sharma R, Florea VG, Bolger AP, et al.: Wasting as an independent predictor of mortality in patients with cystic fibrosis. Thorax 2001, 56:746\u2013750.","journal-title":"Thorax"},{"issue":"Suppl 12","key":"5_CR9","first-page":"55","volume":"79","author":"JM Littlewood","year":"1986","unstructured":"Littlewood JM: An overview of the management of cystic fibrosis. J R Soc Med 1986, 79(Suppl 12):55\u201363.","journal-title":"J R Soc Med"},{"key":"5_CR10","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1093\/ajcn\/55.1.108","volume":"55","author":"BW Ramsey","year":"1992","unstructured":"Ramsey BW, Farrell PM, Pencharz PB, et al.: Nutritional assessment and management in cystic fibrosis: a consensus report. Am J Clin Nutr 1992, 55:108\u2013116.","journal-title":"Am J Clin Nutr"},{"key":"5_CR11","first-page":"963","volume":"21","author":"DL Waters","year":"1995","unstructured":"Waters DL, Dorney SF, Gruca MA, et al.: Hepatobiliary disease in cystic fibrosis patients with pancreatic sufficiency. Hepatology 1995, 21:963\u2013969.","journal-title":"Hepatology"},{"key":"5_CR12","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.jpeds.2004.04.049","volume":"145","author":"D Borowitz","year":"2004","unstructured":"Borowitz D, Baker SS, Duffy L, et al.: Use of fecal elastase-1 to classify pancreatic status in patients with cystic fibrosis. J Pediatr 2004, 145:322\u2013326.","journal-title":"J Pediatr"},{"key":"5_CR13","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/00063198-200211000-00010","volume":"8","author":"S Schibli","year":"2002","unstructured":"Schibli S, Durie P, Tullis E: Proper use of pancreatic enzymes. Curr Opin Pulm Med 2002, 8:542\u2013546.","journal-title":"Curr Opin Pulm Med"},{"key":"5_CR14","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1056\/NEJM199705013361803","volume":"336","author":"SC FitzSimmons","year":"1997","unstructured":"FitzSimmons SC, Burkhart GA, Borowitz D, et al.: Highdose pancreatic-enzyme supplements and fibrosing colonopathy in children with cystic fibrosis. N Engl J Med 1997, 336:1283\u20131289.","journal-title":"N Engl J Med"},{"key":"5_CR15","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0022-3476(95)70153-2","volume":"127","author":"DS Borowitz","year":"1995","unstructured":"Borowitz DS, Grand RJ, Durie PR: Use of pancreatic enzyme supplements for patients with cystic fibrosis in the setting of fibrosing colonopathy. Consensus Committee. J Pediatr 1995, 127:681\u2013684.","journal-title":"J Pediatr"},{"key":"5_CR16","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0022-3476(99)70059-4","volume":"135","author":"A Feranchak","year":"1999","unstructured":"Feranchak A, Sontag M, Wagener J, et al.: Prospective, long-term study of fat-soluble vitamin status in children with cystic fibrosis identified by newborn screen. J Pediatr 1999, 135:601\u2013610.","journal-title":"J Pediatr"},{"key":"5_CR17","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1002\/hep.20864","volume":"42","author":"A Feranchak","year":"2005","unstructured":"Feranchak A, Gralla J, King R: Comparisons of indices of vitamin A status in children with chronic liver disease. Hepatology 2005, 42:782\u2013791.","journal-title":"Hepatology"},{"key":"5_CR18","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/00005176-200209000-00004","volume":"35","author":"D Borowitz","year":"2002","unstructured":"Borowitz D, Baker RD, Stallings V: Consensus report on nutrition for pediatric patients with cystic fibrosis. J Pediatr Gastroenterol Nutr 2002, 35:246\u2013259.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"5_CR19","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1146\/annurev.nu.13.070193.000551","volume":"13","author":"PB Pencharz","year":"1993","unstructured":"Pencharz PB, Durie PR: Nutritional management of cystic fibrosis. Annu Rev Nutr 1993, 13:111\u2013136.","journal-title":"Annu Rev Nutr"},{"key":"5_CR20","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/S0899-9007(00)00351-8","volume":"16","author":"J Dowsett","year":"2000","unstructured":"Dowsett J: An overview of nutritional issues for the adult with cystic fibrosis. Nutrition 2000, 16:566\u2013570.","journal-title":"Nutrition"},{"key":"5_CR21","first-page":"1653","volume-title":"Encyclopedia of Food Science, Food Technology and Nutrition","author":"T Sanders","year":"1993","unstructured":"Sanders T: Essential fatty acids. In Encyclopedia of Food Science, Food Technology and Nutrition. Edited by Macrae R, Robinson RK, Sadler MJ. San Diego: Academic Press; 1993:1653."},{"key":"5_CR22","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1177\/0148607192016002106","volume":"16","author":"MS Nussbaum","year":"1992","unstructured":"Nussbaum MS, Li S, Bower RH, et al.: Addition of lipid to total parenteral nutrition prevents hepatic steatosis in rats by lowering the portal venous insulin\/glucagon ratio. JPEN J Parenter Enteral Nutr 1992, 16:106\u2013109.","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"5_CR23","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1161\/01.CIR.97.10.946","volume":"97","author":"KL Gould","year":"1998","unstructured":"Gould KL, Martucci JP, Goldberg DI, et al.: Short-term cholesterol lowering decreases size and severity of perfusion abnormalities by positron emission tomography after dipyridamole in patients with coronary artery disease. A potential noninvasive marker of healing coronary endothelium [comment]. Circulation 1998, 97:2580\u20132583.","journal-title":"Circulation"},{"key":"5_CR24","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1053\/gast.2001.25542","volume":"121","author":"P Fickert","year":"2001","unstructured":"Fickert P, Zollner G, Fuchsbichler A, et al.: Effects of ursodeoxycholic and cholic acid feeding on hepatocellular transporter expression in mouse liver. Gastroenterology 2001, 121:170\u2013183.","journal-title":"Gastroenterology"},{"key":"5_CR25","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/hep.20370","volume":"40","author":"D Rost","year":"2004","unstructured":"Rost D, Rudolph G, Kloeters-Plachky P, et al.: Effect of high-dose ursodeoxycholic acid on its biliary enrichment in primary sclerosing cholangitis. Hepatology 2004, 40:693\u2013698.","journal-title":"Hepatology"},{"key":"5_CR26","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/ncpgasthep0521","volume":"3","author":"U Beuers","year":"2006","unstructured":"Beuers U: Drug insight: mechanism and sites of action of ursodexycholic acid in cholestasis. Nat Clin Pract Gastroenterol Hepatol 2006, 3:318\u2013328. Several potential mechanisms of action are proposed for UDCA\u2019s effect on cholestasis and one specifically for the cholestasis of CF.","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"5_CR27","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1053\/gast.1996.v111.pm8698195","volume":"111","author":"CM Nieuwkerk Van","year":"1996","unstructured":"Van Nieuwkerk CM, Elferink RP, Groen AK, et al.: Effects of Ursodeoxycholate and cholate feeding on liver disease in FVB mice with a disrupted mdr2 P-glycoprotein gene. Gastroenterology 1996, 111:165\u2013171.","journal-title":"Gastroenterology"},{"key":"5_CR28","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1053\/jhep.2002.34511","volume":"36","author":"F Azzaroli","year":"2002","unstructured":"Azzaroli F, Mehal W, Soroka CJ, et al.: Ursodeoxycholic acid diminishes Fas-ligand-induced apoptosis in mouse hepatocytes. Hepatology 2002, 36:49\u201354.","journal-title":"Hepatology"},{"key":"5_CR29","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.4049\/jimmunol.156.4.1601","volume":"156","author":"H Tanaka","year":"1996","unstructured":"Tanaka H, Makino Y, Miura T, et al.: Ligand-independent activation of the glucocorticoid receptor by ursodeoxycholic acid. Repression of IFN-gamma-induced MHC class II gene expression via a glucocorticoid receptordependent pathway. J Immunol 1996, 156:1601\u20131608.","journal-title":"J Immunol"},{"key":"5_CR30","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1002\/hep.510230627","volume":"23","author":"C Colombo","year":"1996","unstructured":"Colombo C, Battezzati PM, Podda M, et al.: Ursodeoxycholic acid for liver disease associated with cystic fibrosis: a double blind multicenter trial. Hepatology 1996, 23:1484\u20131490.","journal-title":"Hepatology"},{"key":"5_CR31","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1002\/hep.1840160412","volume":"16","author":"C Colombo","year":"1992","unstructured":"Colombo C, Crosignani A, Assaisso M, et al.: Ursodeoxycholic acid therapy in cystic fibrosis-associated liver disease: a dose-response study. Hepatology 1992, 16:924\u2013929.","journal-title":"Hepatology"},{"key":"5_CR32","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/hep.1840150421","volume":"15","author":"C Colombo","year":"1992","unstructured":"Colombo C, Castellani MR, Balistreri WF, et al.: Scintigraphic documentation of an improvement in hepatoboliary excretory function after treatment with ursodeoxycholic acid in patients with cystic fibrosis and associated liver disease. Hepatology 1992, 15:677\u2013684.","journal-title":"Hepatology"},{"key":"5_CR33","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/hep.510270126","volume":"27","author":"A Lindblad","year":"1998","unstructured":"Lindblad A, Glaumann H, Strandvik B: A two year prospective study of the effect of ursodeoxycholic acid on urinary bile acid excretion and liver morphology in cystic fibrosis-associated liver disease. Hepatology 1998, 27:166\u2013174.","journal-title":"Hepatology"},{"issue":"Suppl 1","key":"5_CR34","first-page":"S1","volume":"28","author":"R Sokol","year":"1999","unstructured":"Sokol R, Durie P: Recommendations for management of liver and biliary tract disease in cystic fibrosis. Cystic Fibrosis Foundation Hepatobiliary Disease Consensus Group. JPGN 1999, 28(Suppl 1):S1-S13.","journal-title":"JPGN"},{"key":"5_CR35","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1001\/archderm.1985.01660110063017","volume":"121","author":"JM Garden","year":"1985","unstructured":"Garden JM, Ostrow JD, Roenigk HH, Jr: Pruritis in hepatic cholestasis-pathogenesis and treatment. Arch Dermatol 1985, 121:1415\u20131420.","journal-title":"Arch Dermatol"},{"key":"5_CR36","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1002\/hep.1840110526","volume":"11","author":"EA Jones","year":"1990","unstructured":"Jones EA, Bergasa NV: The pruritis of cholestasis: from bile acids to opiate antagonists. Hepatology 1990, 11:884\u2013887.","journal-title":"Hepatology"},{"key":"5_CR37","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1097\/00005176-199910000-00013","volume":"29","author":"B Yerashalmi","year":"1999","unstructured":"Yerashalmi B, Sokol RJ, Narkewicz MR: Use of rifampin for severe pruritis in children with chronic cholestasis. J Pediatr Gastroenterol Nutr 1999, 29:442\u2013447.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"5_CR38","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0022-3476(85)80316-4","volume":"106","author":"S Ozsoylu","year":"1985","unstructured":"Ozsoylu S, Kocak N, Yuca A: Propranolol therapy for portal hypertension in children. J Pediatr 1985, 106:317\u2013321.","journal-title":"J Pediatr"},{"key":"5_CR39","first-page":"242","volume-title":"Current Clinical Topics in Gastrointestinal Pharmacology","author":"AJ Sanyal","year":"1997","unstructured":"Sanyal AJ, Shiffman ML: Pharmacological treatment of portal hypertension. In Current Clinical Topics in Gastrointestinal Pharmacology. Edited by Lewis JH, Dubois A. London: Blackwell Scientific; 1997:242\u2013275."},{"key":"5_CR40","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1056\/NEJM199508313330904","volume":"333","author":"I Bessan","year":"1995","unstructured":"Bessan I, Ingraud P, Pearson B, et al.: Sclerotherapy with or without octreotide for acute variceal bleeding. N Engl J Med 1995, 333:555\u2013560.","journal-title":"N Engl J Med"},{"key":"5_CR41","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0016-5107(89)72838-8","volume":"35","author":"H Gaudy","year":"1989","unstructured":"Gaudy H, Rosman A, Korssen M: Prevention of stricture formation after endoscopic sclerotherapy of esophageal varices. Gastrointest Endosc 1989, 35:377\u2013380.","journal-title":"Gastrointest Endosc"},{"key":"5_CR42","doi-asserted-by":"crossref","first-page":"280","DOI":"10.7326\/0003-4819-123-4-199508150-00007","volume":"123","author":"L Laine","year":"1995","unstructured":"Laine L, Cook D: Endoscopic ligation compared with sclerotherapy for treatment of esophageal variceal bleeding. A meta-analysis. Ann Intern Med 1995, 123:280\u2013287.","journal-title":"Ann Intern Med"},{"key":"5_CR43","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/00005176-199502000-00011","volume":"20","author":"VL Fox","year":"1995","unstructured":"Fox VL, Carr-Locke DL, Connors PJ, et al.: Endoscopic ligation of esophageal varices in children. J Pediatr Gastroenterol Nutr 1995, 20:202\u2013208.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"5_CR44","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/bjs.1800750504","volume":"75","author":"ER Howard","year":"1988","unstructured":"Howard ER, Stringer MD, Mowat AP: Assessment of injection sclerotherapy in the management of 152 children with esophageal varices. Br J Surg 1988, 75:404\u2013408.","journal-title":"Br J Surg"},{"key":"5_CR45","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/adc.77.6.476","volume":"77","author":"MD Stringer","year":"1997","unstructured":"Stringer MD, McClean P: Treatment of oesophageal varices. Arch Dis Child 1997, 77:476\u2013477.","journal-title":"Arch Dis Child"},{"key":"5_CR46","first-page":"369","volume-title":"Schiff\u2019s Diseases of the Liver","author":"TD Boyer","year":"2003","unstructured":"Boyer TD, Vargus EV: Transjugular intrahepatic portosystemic shunt. In Schiff\u2019s Diseases of the Liver, edn 9. Edited by Schiff ER, Sorrell MF, Maddrey WC. Philadelphia: Lippincott Williams & Williams; 2003:369\u2013382.","edition":"edn 9"},{"key":"5_CR47","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1600-0676.1998.tb00132.x","volume":"18","author":"M Rossle","year":"1998","unstructured":"Rossle M, Siegerstetter V, Huber M, Ochs A: The first decade of the transjugular intrahepatic portosystemic shunt (TIPS): state of the art. Liver 1998, 18:73\u201389.","journal-title":"Liver"},{"key":"5_CR48","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1002\/hep.1840200444","volume":"20","author":"AJ Sanyal","year":"1994","unstructured":"Sanyal AJ: TIPS: the new kid on the block. Hepatology 1994, 20:1092\u20131095.","journal-title":"Hepatology"},{"key":"5_CR49","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0889-8553(05)70120-5","volume":"29","author":"VA Luketic","year":"2000","unstructured":"Luketic VA, Sanyal AJ: Esophageal varices. II. TIPS (transjugular intrahepatic portosystemic shunt) and surgical therapy. Gastroenterol Clin North Am 2000, 29:387\u2013421.","journal-title":"Gastroenterol Clin North Am"},{"key":"5_CR50","first-page":"1111","volume":"50","author":"O Pozler","year":"2003","unstructured":"Pozler O, Krajina A, Vanicek H: Transjugular intrahepatic portosystemic shunt in five children with cystic fibrosis: long-term results. Hepatogastroenterology 2003, 50:1111\u20131114.","journal-title":"Hepatogastroenterology"},{"key":"5_CR51","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1053\/crad.1999.0077","volume":"55","author":"M Fleet","year":"2000","unstructured":"Fleet M, Stanley AJ, Forrest EH, et al.: Transjugular intrahepatic portosystemic stent shunt placement with cystic fibrosis complicated by portal hypertension. Clin Radiol 2000, 55:236\u2013237.","journal-title":"Clin Radiol"},{"key":"5_CR52","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/s002470050190","volume":"27","author":"G Sergent","year":"1997","unstructured":"Sergent G, Gottrand F, Delemazure O, et al.: Transjugular intrahepatic portosystemic shunt in an infant. Pediatr Radiol 1997, 27:588\u2013590.","journal-title":"Pediatr Radiol"},{"key":"5_CR53","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.2214\/ajr.159.6.1442401","volume":"159","author":"SR Kerns","year":"1992","unstructured":"Kerns SR, Hawkins IF, Jr: Transjugular intrahepatic portosystemic shunt in a child with cystic fibrosis. AJR Am J Roentgenol 1992, 159:1277\u20131278.","journal-title":"AJR Am J Roentgenol"},{"key":"5_CR54","first-page":"144","volume-title":"Liver Disease in Children","author":"BL Shneider","year":"2001","unstructured":"Shneider BL: Portal hypertension. In Liver Disease in Children, edn 2. Edited by Suchy F, Sokol R, Ballisteri W. Philadelphia: Lippincott Williams & Wilkins; 2001:144.","edition":"edn 2"},{"key":"5_CR55","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/BF01656319","volume":"9","author":"J Valayer","year":"1985","unstructured":"Valayer J, Hay JM, Gauthier F, et al.: Shunt surgery for treatment of portal hypertension in children. World J Surg 1985, 9:258\u2013268.","journal-title":"World J Surg"},{"key":"5_CR56","unstructured":"Colombo C: Management of CF complications: liver disease. Paper presented at 2005 Cystic Fibrosis Conference. Baltimore, MD; October 20\u201323, 2005."},{"key":"5_CR57","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1432-2277.2004.00013.x","volume":"18","author":"C Colombo","year":"2005","unstructured":"Colombo C, Costantini D, Rocchi A, et al.: Effects of liver transplantation on the nutritional status of patients with cystic fibrosis. Transpl Int 2005, 18:246\u2013255. Nutrition status, including body mass index, bone mineralization, and fat-soluble vitamin levels, all improved in the transplanted group of patients with CF.","journal-title":"Transpl Int"},{"key":"5_CR58","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/S0022-3468(03)00260-4","volume":"38","author":"JA Fridell","year":"2003","unstructured":"Fridell JA, Bond GJ, Mazariegos GV: Liver transplantation in children with cystic fibrosis: a long-term longitudinal review of a single center\u2019s experience. J Pediatr Surg 2003, 38:1152\u20131156.","journal-title":"J Pediatr Surg"},{"key":"5_CR59","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1432-2277.1997.tb00533.x","volume":"10","author":"JP Couetil","year":"1997","unstructured":"Couetil JP, Soubrane O, Houssin DP: Combined heartlung-liver, double lung-liver, and isolated liver transplantation for cystic fibrosis in children. Transpl Int 1997, 10:33\u201339.","journal-title":"Transpl Int"},{"key":"5_CR60","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1034\/j.1399-3046.2003.00021.x","volume":"7","author":"EP Molmenti","year":"2003","unstructured":"Molmenti EP, Squires RH, Nagata D: Liver transplantation for cholestasis associated with cystic fibrosis in the pediatric population. Pediatr Transplant 2003, 7:93\u201397.","journal-title":"Pediatr Transplant"},{"key":"5_CR61","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1136\/adc.81.2.129","volume":"81","author":"SC Ling","year":"1999","unstructured":"Ling SC, Wilkinson JD, Hollman AS, et al.: The evolution of liver disease in cystic fibrosis. Arch Dis Child 1999, 81:129\u2013132.","journal-title":"Arch Dis Child"},{"key":"5_CR62","first-page":"76","volume":"27","author":"B Goodin","year":"2005","unstructured":"Goodin B: Nutrition issues in cystic fibrosis. Pract Gastroenterol 2005, 27:76\u201394.","journal-title":"Pract Gastroenterol"}],"container-title":["Current Treatment Options in Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11938-006-0005-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11938-006-0005-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11938-006-0005-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T19:15:49Z","timestamp":1707938149000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11938-006-0005-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,11]]},"references-count":62,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["5"],"URL":"https:\/\/doi.org\/10.1007\/s11938-006-0005-8","relation":{},"ISSN":["1092-8472","1534-309X"],"issn-type":[{"value":"1092-8472","type":"print"},{"value":"1534-309X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,11]]}}}